These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 22636682)

  • 41. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
    Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
    Luger D; Lipinski MJ; Westman PC; Glover DK; Dimastromatteo J; Frias JC; Albelda MT; Sikora S; Kharazi A; Vertelov G; Waksman R; Epstein SE
    Circ Res; 2017 May; 120(10):1598-1613. PubMed ID: 28232595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial reconstruction in ischaemic cardiomyopathy.
    Castelvecchio S; Pappalardo OA; Menicanti L
    Eur J Cardiothorac Surg; 2019 Jun; 55(Suppl 1):i49-i56. PubMed ID: 31106339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.
    Bax JJ; Schinkel AF; Boersma E; Elhendy A; Rizzello V; Maat A; Roelandt JR; van der Wall EE; Poldermans D
    Circulation; 2004 Sep; 110(11 Suppl 1):II18-22. PubMed ID: 15364832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regenerative medicine approach to repair the failing heart.
    Lionetti V; Ventura C
    Vascul Pharmacol; 2013 Mar; 58(3):159-63. PubMed ID: 23337493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction.
    Cimini M; Garikipati VNS; de Lucia C; Cheng Z; Wang C; Truongcao MM; Lucchese AM; Roy R; Benedict C; Goukassian DA; Koch WJ; Kishore R
    JCI Insight; 2019 Jul; 5(15):. PubMed ID: 31287805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases.
    Silvestre JS
    Thromb Res; 2012 Oct; 130 Suppl 1():S90-4. PubMed ID: 23026676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stem cell engraftment and survival in the ischemic heart.
    Wu KH; Mo XM; Han ZC; Zhou B
    Ann Thorac Surg; 2011 Nov; 92(5):1917-25. PubMed ID: 21955573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stem cells: the building blocks to repair the injured heart.
    Van Oorschot AA; Smits AM; Goumans MJ
    Panminerva Med; 2010 Jun; 52(2):97-110. PubMed ID: 20517194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.
    Quijada P; Toko H; Fischer KM; Bailey B; Reilly P; Hunt KD; Gude NA; Avitabile D; Sussman MA
    Circ Res; 2012 Jun; 111(1):77-86. PubMed ID: 22619278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current understanding of fibrosis in genetic cardiomyopathies.
    Eijgenraam TR; Silljé HHW; de Boer RA
    Trends Cardiovasc Med; 2020 Aug; 30(6):353-361. PubMed ID: 31585768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New directions in strategies using cell therapy for heart disease.
    Itescu S; Schuster MD; Kocher AA
    J Mol Med (Berl); 2003 May; 81(5):288-96. PubMed ID: 12698252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Potentials and limitations of stem cell therapy in myocardial disease].
    Zeus T; Brehm M; Strauer BE
    Z Kardiol; 2005; 94 Suppl 4():IV/100-01. PubMed ID: 16416055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure.
    Bonaros N; Rauf R; Werner E; Schlechta B; Rohde E; Kocher A; Bonatti J; Laufer G
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):249-55. PubMed ID: 17925321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular Therapy for Ischemic Heart Disease: An Update.
    Peng H; Abdel-Latif A
    Adv Exp Med Biol; 2019; 1201():195-213. PubMed ID: 31898788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nearly circumferential delayed contrast enhancement in severe ischemic cardiomyopathy.
    Leurent G; Donal E; Langella B
    Arch Cardiovasc Dis; 2008 Jan; 101(1):70-1. PubMed ID: 18391877
    [No Abstract]   [Full Text] [Related]  

  • 58. Stem-cell angiogenesis and regeneration of the heart: review of a saga of 2 decades.
    Liebson PR
    Clin Cardiol; 2015 May; 38(5):309-16. PubMed ID: 25955103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac regenerative potential of adipose tissue-derived stem cells.
    Hoke NN; Salloum FN; Loesser-Casey KE; Kukreja RC
    Acta Physiol Hung; 2009 Sep; 96(3):251-65. PubMed ID: 19706369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stem Cell and Left Ventricular Assist Device Combination Therapy.
    Poglajen G; Gregoric ID; Radovancevic R; Vrtovec B
    Circ Heart Fail; 2019 Feb; 12(2):e005454. PubMed ID: 30759999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.